Accordingly, in several types of cancer cells, it was shown that the combination of the inhibitors of the prosurvival BCL-2 family members with antimitotics enhanced their efficacy by promoting apoptosis [29,30,31,32]. The gene discussed is BCL2; the disease is cancer.